Oncology & Cancer
High-impact radiopeptide therapy halts neuroendocrine cancer
Research introduced at SNM's 58th Annual Meeting could be a sign of hope for patients with neuroendocrine cancer not responding well to standard therapies. Most radiotherapies use medical isotopes that emit beta radiation. ...
Jun 6, 2011
0
0
